ArticleGlobalization and health2026
Capitalising (on) industrial epidemics: examining the influence of the 'Big Three' asset managers on corporate governance in key health-harming commodity industries.
Article in Globalization and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn recent decades, the Big Three asset managers (BlackRock, Vanguard, State Street) have emerged to be among the top shareholders in thousands of listed companies worldwide. Accordingly, they have considerable influence on corporate decision-making. This paper aimed to examine the influence of the Big Three on the governance of leading corporations in key health-harming commodity industries responsible for a large burden of preventable death and disease worldwide (i.e., industrial epidemics).
methodsWe used an innovative combination of methods and data sources. We analysed share-ownership in 40 selected corporations across 10 major health-harming commodity industries. We then examined the voting behaviour of the Big Three with respect to 61 proposals put to vote at the 2024 shareholder meetings of these corporations (28/40). These proposals related to public health, social and environmental issues, as well as shareholder payouts and political lobbying and expenditure. Following this, we explored key characteristics of the ‘environmental, social, and governance’ (ESG) funds marketed by the Big Three.
resultsThe Big Three were the most prominent shareholders across the selected corporations. In 2024, the Big Three overwhelmingly voted against proposals calling for the incorporation of social and environmental objectives into the policies and strategies of these corporations, and invariably voted in favour of proposals seeking to boost shareholder payouts and authorise political activities. The majority (54/73) of the Big Three’s identified ESG funds included one or more of the identified corporations, despite their well-documented health-harming products and practices.
conclusionsThe Big Three appear to be reinforcing shareholder primacy in health-harming commodity industries, including by undermining many shareholder-led social and environmental initiatives, which risks perpetuating widespread health inequities. States need to take greater action to address industrial epidemics, including through regulating private finance in ways that prioritise health, equity, and sustainability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.